Matthew Johnson, M.D.
Practice: DLV Vision
Specialty: Ophthalmology
Office locations: Westlake Village, Camarillo
Dr. Matthew C. Johnson, M.D., completed his ophthalmology residency at the University of Michigan Kellogg Eye Center and his vitreoretinal surgery fellowship through the USC Roski Eye Institute / Retina Vitreous Associates program in Los Angeles. Specializing in vitreoretinal surgery and retinal diseases, he focuses on the medical and surgical management of retinal detachment, diabetic retinopathy, macular degeneration, retinal vascular disease, and complex vitreoretinal disorders.
Dr. Matthew C. Johnson, M.D., completed his ophthalmology residency at the University of Michigan Kellogg Eye Center and his vitreoretinal surgery fellowship through the USC Roski Eye Institute / Retina Vitreous Associates program in Los Angeles. Specializing in vitreoretinal surgery and retinal diseases, he focuses on the medical and surgical management of retinal detachment, diabetic retinopathy, macular degeneration, retinal vascular disease, and complex vitreoretinal disorders.
There are no reviews yet. Please check back in a day or two.
DLV Vision: Westlake Village
#150
Westlake Village, CA 91361
Dr. Matthew C. Johnson, M.D., is a vitreoretinal surgeon specializing in the medical and surgical treatment of retinal diseases, including retinal detachment, diabetic retinopathy, macular degeneration, retinal vascular disease, and complex disorders of the retina and vitreous. He completed his vitreoretinal surgery fellowship at the USC Roski Eye Institute / Retina Vitreous Associates Combined Fellowship Program in Los Angeles and his ophthalmology residency at the University of Michigan Kellogg Eye Center.
His commitment to education has been recognized with the USC Roski Eye Institute Fellow of the Year Teaching Award and the University of Michigan Walter R. Parker Award for Excellence in Teaching. Dr. Johnson continues to teach and supervise USC ophthalmology residents and vitreoretinal surgery fellows in both the clinic and operating room. He has served as a co-investigator on clinical trials evaluating emerging treatments for retinal diseases, and his research has been recognized at leading ophthalmology and retina conferences.
